Pharma-Bio Serv (PBSV) EBITDA Margin Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -704.00 |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 82.00 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 2,736.00 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -1,252.00 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 2,741.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -56.00 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 1,334.00 |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -1,187.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1,187.00 |
| Oct 31, 2025 | -984.00 |
| Jul 31, 2025 | -2,373.00 |
| Apr 30, 2025 | -972.00 |
| Jan 31, 2025 | -1,082.00 |
| Oct 31, 2024 | 7,912.00 |
| Jul 31, 2024 | -2,302.00 |
| Apr 30, 2024 | -1,843.00 |
| Jan 31, 2024 | -2,552.00 |
| Oct 31, 2023 | -446.00 |
| Jul 31, 2023 | -295.00 |
| Apr 30, 2023 | -443.00 |
| Jan 31, 2023 | -388.00 |
| Oct 31, 2022 | -520.00 |
| Jul 31, 2022 | 48.00 |
| Apr 30, 2022 | -361.00 |
| Jan 31, 2022 | -323.00 |
| Oct 31, 2021 | -9,449.00 |
| Jul 31, 2021 | -836.00 |
| Apr 30, 2021 | 548.00 |
| Jan 31, 2021 | 7,345.00 |
| Oct 31, 2020 | -624.00 |
| Jul 31, 2020 | 1,789.00 |
| Apr 30, 2020 | 2,103.00 |
| Jan 31, 2020 | 2,113.00 |
| Oct 31, 2019 | 1,853.00 |
| Jul 31, 2019 | 974.00 |
| Apr 30, 2019 | 708.00 |
| Jan 31, 2019 | 340.00 |
| Oct 31, 2018 | 927.00 |
| Jul 31, 2018 | 856.00 |
| Apr 30, 2016 | -1,425.00 |
| Jan 31, 2016 | -721.00 |
| Oct 31, 2015 | -1,731.00 |
| Jul 31, 2015 | -890.00 |